Category: CannabisNewsWire Release

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Receives Initial Orders from Mexico, Spain

Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, is expanding internationally. The company’s Flora Beauty division received its first-ever orders for its Mind Naturals and Awe CBD skincare brands for the Spanish and Mexican markets; the company plans to ship the product this month. Flora Beauty’s Mind Naturals brand is designed with young consumers who are just starting a skincare routine while its the AWE brand targets consumers who value customized and personal experiences. The Mind Naturals line was recently named a top-12 finalist in a global pitch competition sponsored by Glosswire. The company also announced that legal and strategy vice president Damian Lopez has resigned to focus on other entrepreneurial ventures and board and advisory roles. “We are excited to expand our global reach over the coming months through Flora Beauty’s brands,” said Flora Growth CEO Luis Merchan in the press release. “The next few years will be pivotal for the evolution and expansion of the international cannabis market, and with our rapidly expanding portfolio of brands we intend to be at the forefront of this evolution.” To view the full press releases, visit https://cnw.fm/lgtcU   About Flora Growth Corp. Flora is building a connected, design-led collective of plant-based wellness and lifestyle brands that delivers the most compelling customer experiences in the world, one community at a time. As the operator of one of the largest outdoor cannabis cultivation facilities, Flora leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its diverse business divisions of cosmetics, hemp textiles, and food and beverage. For more information about the company, please visit www.FloraGrowth.ca. NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://cnw.fm/FLGC About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer Do you have questions or are you interested in working with CNW? Ask our Editor CannabisNewsWire (CNW) Denver, Colorado www.CannabisNewsWire.com 303.498.7722 Office Editor@CannabisNewsWire.com CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Announces Q3 2021 Results, Including 93% YOY Revenue Increase

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis operator and house of premium brands, today announced 2021 third quarter financial results. Among the highlights, the company reported a 93% increase in third quarter year-over-year revenue. “In the third quarter, we made excellent progress in laying additional building blocks in our core operating states of Florida, Michigan and California to become more vertically integrated where it will be most profitable,” said Brad Rogers, RWB chairman and CEO. “This will help drive increased revenue and margins for the company. Simultaneously, we are gaining significant market share with our premium Platinum Vape(TM) (‘PV’) and exclusively licensed High Times(R) branded products in select markets as evidenced by ArcView/Greentank’s 2021 Q3 Industry Vape Report, which named Platinum Vape as the No. 1 brand vape cartridge in Michigan.”

To view the full press release, visit https://cnw.fm/YZsjr

About Red White & Bloom Brands Inc.

The company is positioning itself to be one of the top three multistate cannabis operators active in the U.S. legal cannabis and hemp sector. RWB is predominantly focusing its investments on the major U.S. markets, including Florida, Michigan, Illinois, Massachusetts, Arizona and California with respect to cannabis, and the U.S. and internationally for hemp-based CBD products. For more information about the company, visit www.RedWhiteBloom.com.

NOTE TO INVESTORS: The latest news and updates relating to RWBYF are available in the company’s newsroom at https://cnw.fm/RWBYF

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CBDNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Inks Agreements with Leading Health and Beauty Company, CBD Beverage Company

Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, has signed a definitive agreement with Avaria Health & Beauty Corp. Based on the agreement, the two companies will form a joint venture (“JV”), named FloVaria Corp., aimed to facilitate the sale of itsaward-winning KaLaya brand; sales efforts will be directed in Latin America (“LATAM”). KaLaya has currently sold more than a million units throughout Canada and is carried in major retail locations including Walmart and Loblaws, where the brand has earned the number-two customer loyalty rating in the natural-value, skin-care category. The agreement increases the value of FLGC’s Colombian distribution channels, which currently numbers more than 2,500. The agreement calls for Flora Growth’s wholly owned, GMP-certified manufacturing facility to produce the cannabinoid-infused products that will be sold through the JV. In addition, Flora will be responsible for distribution, supply chain, and marketing support of KaLaya’s pain-management products in Colombia, Mexico and other LATAM countries, while Avaria will initially provide the finished product to the JV company. In addition, the company also announced that it is entering the cannabis beverage market. The company has entered a licensing agreement with Tonino Lamborghini to produce and distribute CBD beverages. The Tonino Lamborghini product line will launch early next year. Under the agreement, Flora Growth will retain the right of first refusal to distribute any cannabis products globally under the Tonino Lamborghini brand. “We are excited to partner with such a well-known luxury brand as Tonino Lamborghini, which already boasts a very successful line of beverages and aligns with Flora’s brand portfolio of high-end products,” said Flora Growth president and CEO Luis Merchan in the press release. “This partnership is yet another step in the execution of Flora’s strategic plan to build a world-class house of brands and is also a major component of our sales and distribution strategy in the lucrative U.S. market.”

To view the full press releases, visit https://cnw.fm/5mFg2  and https://cnw.fm/Zxj8Y

About Flora Growth Corp.

Flora is building a connected, design-led collective of plant-based wellness and lifestyle brands that delivers the most compelling customer experiences in the world, one community at a time. As the operator of one of the largest outdoor cannabis cultivation facilities, Flora leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its diverse business divisions of cosmetics, hemp textiles, and food and beverage. For more information about the company, please visit www.FloraGrowth.ca.

NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://cnw.fm/FLGC

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.

420 with CNW — Study Finds That Legalizing Cannabis Doesn’t Cause Increase in Traffic Injuries

A new study has discovered that the move to legalize cannabis in Canada did not translate into a rise in traffic injuries. The study’s findings were reported in the “Drug and Alcohol Dependence” journal.

The objective of the researchers was to investigate claims from prohibitionists who argue that enacting laws to legalize marijuana would make roads less safe. Canada approved laws to legalize marijuana, which took effect in October 2018.

For their study, the researchers conducted an analysis on emergency-department data gathered from the Alberta and Ontario provinces between April 2015 to December 2019. The researchers found no evidence supporting the claims, noting in their report that implementing the Cannabis Act across the country wasn’t linked to evidence of substantial post-legalization changes in visits to the emergency departments in the aforementioned provinces due to traffic injuries among young drivers in particular, as well as all drivers in general.

The researchers say that this was despite the fact that the momentum toward legalizing the recreational use of marijuana globally had raised concerns that these laws could lead to a significant increase in marijuana-impaired driving and, subsequently, traffic-related injuries.

In a press release, Russ Callaghan, the lead author of the study, stated that the research’s findings were a bit surprising, noting that the results could have been influenced by the enactment of stricter federal laws. He gave the example of Bill C-46, which imposed serious penalties on impaired driving under the influence of alcohol and marijuana as well as combined alcohol and marijuana use.

In addition to this study, prior research exists that also challenged the idea that legalizing marijuana contributes to increased traffic risks.

In a separate 2019 report, a congressional research body in the United States stated that concerns expressed by legislators over marijuana legalization making roads more dangerous may not be based on facts. The researchers tasked with investigating this discovered that evidence about the ability of marijuana to impair driving was currently inconclusive.

Other studies have also found on different occasions that traffic fatalities don’t grow after states legalize cannabis. For instance, research that was recently reported in the “Journal of the American Medical Association” discovered that small CBD doses had no considerable impact on an individual’s driving.

However, the study did find that similar amounts of THC were linked to short-term impairment, which the researchers equated to the impairment observed in drivers with a below 1% blood alcohol concentration.

This research provides further proof that allowing cannabis companies such as Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) to operate is unlikely to worsen the road accident situation in the jurisdictions where marijuana is legal.

NOTE TO INVESTORS: The latest news and updates relating to Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) are available in the company’s newsroom at https://cnw.fm/RWBYF

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Biden’s Pick for Top FDA Job Has Prescribed Cannabis-Based Medicine

President Joseph Biden isn’t a big fan of broad, comprehensive cannabis reform. Even though plenty of Democrats and even some Republicans have thrown their weight behind broad legalization, Biden favors decriminalizing cannabis, legalizing medical cannabis, and giving states the freedom to craft their own marijuana policies. This has been a bone of contention for many lawmakers, especially those from the left, and Senate Majority Leader Chuck Schumer stated that he would advance broad federal legalization with or without the president. A recent move by Biden may be a sign of his preference for medical cannabis.

On Friday, Biden announced that he has nominated a new Food and Drug Administration (“FDA”) commissioner who, coincidentally, has acknowledged that cannabis has medical potential and has even prescribed a cannabinoid-based drug as a physician. A cardiologist by trade, Robert Califf served as the 22nd FDA commissioner from February 2016 to January 2017 after President Barack Obama nominated him in 2015. Prior to that, he had been serving as the deputy commissioner of the United States Food and Drug Administration’s Office of Medical Products and Tobacco. He was hired by Alphabet Inc. (Google’s parent company) in 2019 as the head of Medical Strategy and Policy.

Califf is a tenured professor of cardiology at the Duke University School of Medicine, and he is the founding director of what is said to be the largest academic research organization on the globe, the Duke Clinical Research Institute. While he hasn’t been very vocal about cannabis, he made his views on the subject known during a 2016 cannabis research summit hosted by the federal government. He acknowledged that the controversial plant has several medical applications and said that the FDA was interested in advancing cannabis research and development.

He mentioned the treatment of epilepsy, AIDS wasting, cancer, neuropathic pain, spasticity, multiple sclerosis, and cancer as well as chemotherapy-induced nausea as some of the possible uses of cannabis and cannabinoid-infused products. Furthermore, he stated that he had prescribed cannabis-related treatments to patients afflicted with wasting cachectic syndrome due to extreme heart failure in his cardiology practice. Even though the FDA may not have found that cannabis can be a safe and effective treatment, he said at the time thatit doesn’t mean the drug has zero good uses. Califf added that we need additional studies to learn more about marijuana’s possible risks and benefits.

In 2019, he authored an op-ed advocating for strict regulation of vapes and the ban of flavored vape products to reduce the risks of lung disease in the wake of the 2019 vape lung illness outbreak. He later said that an outright ban on all vape products would be impractical and that prohibition would perpetuate a stigma that would keep addicts from seeking treatment.  

If Califf takes office as FDA commissioner, there is hope that he will be less hostile to the products made by cannabis companies such as Hero Technologies Inc. (OTC: HENC) since he has some experience with the therapeutic potential of marijuana products.

NOTE TO INVESTORS: The latest news and updates relating to Hero Technologies Inc. (OTC: HENC) are available in the company’s newsroom at https://cnw.fm/HENC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – AmeriCann (ACAN) Announces 300% Annual Revenue Increase from Flagship Project

AmeriCann (OTCQB: ACAN), a cannabis company that develops state-of-the-art cultivation, product manufacturing and distribution facilities, today announced financial and operational updates for its flagship project, the Massachusetts Cannabis Center. Located on a 52-acre parcel in southeastern Massachusetts, the project is permitted for 987,000 sq. ft. of cannabis cultivation and processing infrastructure, which is being developed in phases to support multiple tenants in medical and adult-use cannabis markets. “AmeriCann’s operating revenue for the year ending September 2021 increased by over 300% from the prior year,” said CFO Ben Barton. “The strong top-line growth reflects four consecutive quarters of accelerating revenue. We look forward to releasing our complete quarterly and annual financial results as they are completed next month.”

To view the full press release, visit https://cnw.fm/c7JoD

About AmeriCann

AmeriCann develops and leases cannabis cultivation, processing and product manufacturing facilities. The company uses greenhouse technology, which is superior to the current industry standard of growing cannabis in warehouse facilities under artificial lights. According to industry experts, by capturing natural sunlight, greenhouses use 25% fewer lights, and utility bills are up to 75% less than in typical warehouse cultivation facilities. As such, AmeriCann’s “Cannopy” cultivation system enables cannabis to be produced with a greatly reduced carbon footprint, making the final product less expensive. Additionally, greenhouse construction costs are nearly half of warehouse construction costs. AmeriCann is also designing GMP Certified cannabis extraction and product manufacturing infrastructure. The company has secured licenses to produce cannabis infused products including beverages, edibles, topicals and concentrates. AmeriCann plans to operate a marijuana product manufacturing business at the Massachusetts Cannabis Center. For more information about the company, visit www.AmeriCann.co.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW – New Cannabis Initiative to Push for Federal Legalization Launched

As more states across the United States legalize cannabis for medical and recreational use, the push to federally legalize the herb grows. Thus far, 18 states and Washington, DC, have legalized the recreational adult use of cannabis. Still, cannabis remains illegal to sell, use or possess under federal law, which has in turn made banks refrain from backing the marijuana industry, for fear that it would cause federal issues. Now major marijuana companies are supporting celebrity-infused campaigns to enlist cannabis users to pressure Congress to legalize the plant countrywide.

Earlier last week, the Cannabis in Common initiative was launched to make it easier for supporters to call or email their congressional representatives. State-licensed companies also plan to add more information to their applications, display posters in shops, email their consumers and encourage customers to get involved.

The cofounder of a marijuana firm, Seth Rogen, who is  also an actor, stated that legalizing marijuana was long overdue, adding that it would happen if enough noise was made. In addition, prolegalization groups that have mounted federal and state campaigns for a long time now hope that this new initiative will break ground by mobilizing consumers of major players’ products in the marijuana industry.

U.S. Cannabis Council CEO Steve Hawkins stated that the council felt there existed a bigger group of people whose opinion on the matter of legalization would be helpful but was unheard.

More than 10 firms have signed on to the initiative, including publicly traded corporations such as Cronos Group, Curaleaf Holdings,Canopy Growth, and Pax, which is a vaping brand.

However, while most are in support of this move, there are those who criticize it, believing that it goes against all that is right. This includes Smart Approaches to Marijuana, a national marijuana anti-legalization group. Kevin Sabet, who is the CEO of the group and a former official under the Obama administration, stated that the campaign was putting profit over public health.

Additionally, a number of pro legalization not-for-profit groups are also keeping away from this initiative. This includes the Drug Policy Alliance, which believes that the campaign isn’t committed to expunging past cannabis convictions and helping individuals and communities who have been overly affected by cannabis arrests and the war on drugs.

In addition to this, NORML, one of the oldest legalization groups in the country, is also steering clear of this campaign. The group’s political director, Justin Strekal, stated that it was instead focused on certain congressional measures to make cannabis legal on the federal scale.

If these initiatives eventually bear fruit, a lot more people are likely to get comfortable trying medical cannabis, and this would provide an opportunity for helpful platforms such as RYAH MD, which is owned by RYAH Group Inc. (CSE: RYAH), to serve more people.

NOTE TO INVESTORS: The latest news and updates relating to RYAH Group Inc. (CSE: RYAH) are available in the company’s newsroom at https://cnw.fm/RYAH

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Montana Committee Recommends Reversal of CBD Ban in Cannabis Shops

Earlier this year, the governor of Montana signed House Bill 701 into law, setting the stage for Montana to launch a recreational cannabis market in January 2022. Sponsored by Republican Representative Mike Hopkins, the legislation allowed the sale of adult-use cannabis in counties that had voted in favor of the legalization initiative to adults 21 and older and charged the state Department of Revenue with developing administrative rules and issuing recreational cannabis business licenses. However, two proposed rules by the department drew the ire of industry stakeholders who claimed that the rules were not correct interpretations of the legalization bill.

Officials from the Department of Revenue have informed the Revenue Interim Committee that they have listened to several comments from individuals who are unsatisfied with the proposed rules. According to Cannabis Control Division attorney Courtney Cosgrove, the revenue department is now working to align the proposed rules with the recreational cannabis framework that was signed into law in May. But with the recreational market set to begin sales on Jan. 1, 2022, the department has a tight window to make the necessary changes.

According to Cosgrove, members of the committee meet once a week to every two weeks to discuss the proposed rules for Montana’s forthcoming recreational cannabis market. One of the rules that raised eyebrows was a proposed ban on the sale of CBD (cannabidiol) products in marijuana dispensaries. House Bill 701 requires that legal industrial hemp have less than 0.3% THC, the main chemical agent responsible for marijuana’s psychoactive effects. The state’s revenue department assumed that this ban also extended to CBD, which isn’t psychoactive.

Senate Minority leader Jill Cohenour argued that the ban wasn’t in line with the cannabis legislation’s provisions. She was part of a bipartisan working group that carried the bill through the Senate, and she says that lawmakers have also heard complaints about the proposed ban on CBD products. With demand for cannabidiol-infused products at an all-time high, the CBD market is projected to be worth $19.5 billion by 2025. Unsurprisingly, plenty of producers were preparing to cash in on the lucrative CBD market before the proposed CBD ban sent them into a panic.

The other contentious rule would have given the state revenue department the ability to revoke or suspend a cannabis worker who had been convicted of any crime or a cannabis-related crime in another state. This proposed rule was especially controversial because it would essentially punish the people who were already being punished by prohibition and prevent them from getting gainful employment. J.D. Pepper Petersen, a key figure in the 2020 legalization campaign, says the department should empower individuals to obtain any legal work they can, not put up even more barriers to employment.

Such a ban on the sale of CBD products in recreational cannabis ports would be extremely unfair to even far-off dedicated companies such as Simply Sonoma Inc., which manufacture CBD medicinal products that are in compliance with federal law.

NOTE TO INVESTORS: The latest news and updates relating to Simply Sonoma Inc. are available in the company’s newsroom at https://cnw.fm/Sonoma

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Global Technologies Ltd (GTLL) Announces LOI to Acquire Tersus Power

Global Technologies (OTC: GTLL), a holding corporation with operations engaged in the online sales of CBD and hemp-related products, the acquisition of intellectual property in the safety and security space, and as a portal for entrepreneurs to provide immediate access to live shopping, e-commerce, distribution and logistics, today announced its entry into a letter of intent to acquire Tersus Power. Tersus is focused on designing a safe, adaptable and affordable hydrogen fueling station that allows for rapid development and deployment of hydrogen fueling infrastructure while minimizing the risk to investors. “This is an exciting time for the Global Technologies shareholders,” said Jimmy Wayne Anderson, president of Global Technologies Ltd. “Tersus brings with it a management team with acute leadership skills and a world-class engineering lineup.”

To view the full press release, visit https://cnw.fm/Tejbj

About Global Technologies Ltd

Global Technologies, based in St. Petersburg, Florida, is a holding corporation, which, through its subsidiaries, has operations engaged in the online sales of CBD and hemp-related products, the acquisition of intellectual property in the safety and security space, and as a portal for entrepreneurs to provide immediate access to live shopping, e-commerce, product placement in brick-and-mortar retail outlets and logistics. For further information, please visit the company’s website at www.GlobalTechnologiesLtd.info.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — How the Fashion Industry Is Giving Hemp Fiber a Hand Up

Farmers were allowed to legally cultivate industrial hemp after the 2018 farm bill was passed. Before the plant was banned, it was widely grown in different parts of the country. The plant’s seed, grain and fiber are used in different industries, including the pharmaceutical, animal care, construction and fashion industries.

Retailers and consumers in the fashion industry are keen on using the plant in their many processes, as it provides a sustainable alternative to synthetic materials as well as cotton. This interest continues to grow as the environmental crisis in fashion also intensifies.

Synthetic fibers are cheaper to mass produce, which may explain why they account for 60% of global fiber consumption. The issue isn’t mass production; rather, it’s the minute pieces of plastic shedding from clothes made from these materials that are the problem. These micro-plastics make up almost 35% of micro-plastics in the ocean.

Additionally, natural fibers require a lot of resources for production to occur. For instance, cotton needs roughly 712 gallons of water in order to produce a T-shirt from the material.

This makes the use of hemp fiber, which is not only sustainable but also biodegradable, appealing. However, before its fiber can be produced on a large scale, the United States needs to reconstruct its infrastructure.

Patagonia Materials Developer’s Alexandra LaPierre, stated that hemp was a low-till crop that needed very little water as well as no pesticides, which made the process of cultivating the plant a naturally sustainable practice. Most farmers in America use hemp as a rotation crop as it replenishes nutrients in the soil.

In order to decrease the waste produced by fast fashion and alleviate climate change, companies are focused on using more sustainable ways to afford consumers trendy styles while also producing less waste. Some companies are already developing solutions to help build an ecosystem around industrial hemp by investing millions that will facilitate the advancement of hemp processing technologies, linking the supply chain and connecting farmers to different partners in the country.

One of these companies is Bastcore, which revealed that it had received about $3 million in financing, which will be used to advance its decortication and degumming technology. Decortication refers to the stripping of the outer layer of the plant. On the other hand, degumming helps separate the plant’s fiber from its woody core and also removes pectins and sticky lignins.

The company plans to employ a huge workforce in order to meet the fashion market’s demand for industrial hemp in the future. As companies such as Flora Growth Corp. (NASDAQ: FLGC) expand their hemp textile operations, demand for hemp strains specifically developed for fiber production is likely to surge.

NOTE TO INVESTORS: The latest news and updates relating to Flora Growth Corp. (NASDAQ: FLGC) are available in the company’s newsroom athttps://cnw.fm/FLGC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.